Literature DB >> 16413114

An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells.

Iris Lavi1, Dana Friesem, Shimona Geresh, Yitzhak Hadar, Betty Schwartz.   

Abstract

Anti-proliferative and pro-apoptotic activities of fractions of Pleurotus ostreatus were examined using HT-29 colon cancer cells in vitro. A hot-water-soluble fraction of the mycelium of the liquid cultured mushroom was partially isolated and chemically characterized as a low-molecular-weight alpha-glucan. HT-29 cells were exposed to the different isolates and significant inhibition of proliferation was obtained in a dose-dependent manner. Proliferation inhibition was shown to be the result of apoptotic induction because the pro-apoptotic molecules Bax and cytosolic cytochrome-c were upregulated. Fluorescence-activated cell sorter analyses of polysaccharide-treated HT-29 cells showed a high percentage of Annexin-positive cells. Here, we describe a newly identified low-molecular-weight alpha-glucan with promising anti-tumorigenic properties, and demonstrate its direct effect on colon cancer cell proliferation via induction of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413114     DOI: 10.1016/j.canlet.2005.12.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  33 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 2.  Medicinal mushroom: boon for therapeutic applications.

Authors:  Vivek Kumar Chaturvedi; Sonam Agarwal; Krishna Kumar Gupta; Pramod W Ramteke; M P Singh
Journal:  3 Biotech       Date:  2018-07-23       Impact factor: 2.406

Review 3.  Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer.

Authors:  Betty Schwartz; Yitzhak Hadar
Journal:  Ann Transl Med       Date:  2014-02

4.  The Concentration and Probabilistic Health Risk of Potentially Toxic Elements (PTEs) in Edible Mushrooms (Wild and Cultivated) Samples Collected from Different Cities of Iran.

Authors:  Hadis Karami; Nabi Shariatifar; Shahrokh Nazmara; Mojtaba Moazzen; Babak Mahmoodi; Amin Mousavi Khaneghah
Journal:  Biol Trace Elem Res       Date:  2020-04-20       Impact factor: 3.738

5.  Effect of the polysaccharide extract from the edible mushroom Pleurotus ostreatus against infectious bursal disease virus.

Authors:  Mircea Selegean; Mihai V Putz; Tatiana Rugea
Journal:  Int J Mol Sci       Date:  2009-08-18       Impact factor: 6.208

6.  Establishment of an efficient transformation system for Pleurotus ostreatus.

Authors:  Min Lei; Xiangli Wu; Jinxia Zhang; Hexiang Wang; Chenyang Huang
Journal:  World J Microbiol Biotechnol       Date:  2017-11-21       Impact factor: 3.312

7.  Characterization of Pleurotus ostreatus biofilms by using the calgary biofilm device.

Authors:  Lorena Pesciaroli; Maurizio Petruccioli; Stefano Fedi; Andrea Firrincieli; Federico Federici; Alessandro D'Annibale
Journal:  Appl Environ Microbiol       Date:  2013-07-26       Impact factor: 4.792

8.  Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.

Authors:  Andrej Jedinak; Daniel Sliva
Journal:  Int J Oncol       Date:  2008-12       Impact factor: 5.650

9.  Antitumour effect of glucooligosaccharides obtained via hydrolysis of α-(1 → 3)-glucan from Fomitopsis betulina.

Authors:  Arkadiusz Czerwonka; Adrian Wiater; Iwona Komaniecka; Paulina Adamczyk; Wojciech Rzeski; Małgorzta Pleszczyńska
Journal:  Mol Biol Rep       Date:  2019-08-22       Impact factor: 2.316

10.  Chemopreventive activity of bioactive fungal fractions isolated from milk-supplemented cultures of Cerrena unicolor and Pycnoporus sanguineus on colon cancer cells.

Authors:  Mateusz Pięt; A Zając; R Paduch; M Jaszek; M Frant; D Stefaniuk; A Matuszewska; K Grzywnowicz
Journal:  3 Biotech       Date:  2021-01-01       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.